论文信息 - Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial - 字舞流文

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial

D. Schadendorf | C. Mauch | S. Love | L. Zimmer | V. Urbonas | M. Middleton | P. Corrie | C. Mauch | S. Danson | E. Plummer | E. Marshall | M. Wheater | M. Goff | C. Scudder | S. Mohammed